Meds Apotek AB (MEDS) Fair Value & Analysis
Consumer Cyclical · SE · Market cap 514M SEK
Fair value as of: Aug 14, 2026
From 11 valuation models · updated today
Share price +28.2% over the past month.
Below-average quality, and screening another 67% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (kr 11.44). The favourable scenario is already priced in.
- Solid but not exceptional quality (46/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (11 months)
White line = price, green steps = our fair value per fiscal year. As of Aug 14, 2026.
How to read this chart
11‑month range kr 20.50 – kr 58.00 · fair‑value band kr 6.86 – kr 11.44 · the kr 27.70 price screens above the kr 9.15 fair value. As of Aug 14, 2026.
Analysis
Meds Apotek AB (MEDS) currently trades at kr 27.70, while our model-based Fair Value estimate is kr 9.15, implying the stock looks roughly 67.0% overvalued today. The Quality Score stands at 46/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Meds Apotek AB generated revenue of 1.1B SEK at a net margin of 1.4%. Revenue grew 17.6% year over year. It earns a return on equity of 14.8%. The stock trades on a trailing P/E of 34.6. Fundamentals as of Aug 14, 2026
Our scenario range runs from kr 6.86 (bear case) to kr 11.44 (bull case); at kr 27.70, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 64% below its 52-week high and 36% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -52% fair-value upside, at -67%, MEDS screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 11 models by family
Widest divergence: DCF Models (kr 31.30) versus Asset-Based (kr 4.63). Highest evidence: Growth-Adj P/E (68).
Notify me when MEDS reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 14, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 47 · Market factors (momentum, volatility) 30
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Meds Apotek AB operates as an online pharmacy that sells prescription and non-prescription medicines in Sweden. The company offers various products, including beauty products, dietary supplements, children's products, facial care, vitamins and supplements, oral care for animals, pet accessories, fur care, allergy medicine, sunscreen and body sunscreen, eye …
Full company description
Meds Apotek AB operates as an online pharmacy that sells prescription and non-prescription medicines in Sweden. The company offers various products, including beauty products, dietary supplements, children's products, facial care, vitamins and supplements, oral care for animals, pet accessories, fur care, allergy medicine, sunscreen and body sunscreen, eye mask, sleep mask, earplugs, hearing aids, contact lenses, fitness products, electric toothbrush, heat tools for hair, food and drinks, and home & household products. The company was incorporated in 2016 and is based in Hägersten, Sweden.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2023 – FY2025 · reported fiscal years
Meds Apotek AB reported revenue of kr 1.0B in FY2025 versus kr 655M in FY2023, a compound +23.9%/yr. Reported net income was kr 7.7M in FY2025.
MEDS screens 67% overvalued. Compare with Amazon.com, Inc →
Peer Group
Internet Retail · 109 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Internet Retail median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Internet Retail stocks, each showing price versus our Fair Value estimate (as of Aug 14, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Amazon.com, Inc AMZN | $267.28 | $127.67 | -52% |
| Alibaba Group BABA | $125.22 | $76.00 | -39% |
| PDD Holdings PDD | $89.04 | $224.27 | +152% |
| MercadoLibre, Inc MELI | $1,828 | $798.98 | -56% |
| DoorDash, Inc DASH | $212.00 | $38.64 | -82% |
| Sea Limited SE | $128.11 | $52.70 | -59% |
| eBay Inc EBAY | $102.31 | $60.13 | -41% |
| JD.com, Inc JD | €27.00 | €31.73 | +18% |
| Coupang, Inc CPNG | $16.32 | $2.79 | -83% |
| Delivery Hero SE DHER | €37.04 | €12.71 | -66% |
Compare Meds Apotek AB with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Meds Apotek AB (MEDS) overvalued or undervalued?
What is the fair value of MEDS?
What is the quality score of MEDS?
What is the revenue of Meds Apotek AB (MEDS)?
What is the net profit margin of MEDS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Meds Apotek AB and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.